Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02475382
Title Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen (CheckMate 169)
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Bristol-Myers Squibb
Age Groups: adult
Covered Countries CAN

No variant requirements are available.